P-glycoprotein and GSTP1-1 in Testis Cancer
Author Information
Author(s): A. Katagiri, Y. Tomita, T. Nishiyama, M. Kimura, S. Sato
Primary Institution: Niigata University School of Medicine
Hypothesis
The study investigates the correlation of P-glycoprotein and GSTP1-1 expression with drug resistance in testis cancer.
Conclusion
P-glycoprotein and GSTP1-1 are expressed more frequently in non-seminomatous germ cell tumors, suggesting their role in drug resistance.
Supporting Evidence
- P-glycoprotein was detected in 8% of seminomas and 62% of non-seminomatous germ cell tumors.
- GSTP1-1 was found to be expressed more in teratomas compared to seminomas.
- Lower amounts of GSTP1-1 were observed in seminomas than in teratomas.
- Expression of Pgp and GSTP1-1 correlated positively with each other.
Takeaway
This study looked at how certain proteins in testis cancer might make it harder for medicines to work. They found that some types of testis cancer have more of these proteins.
Methodology
The study examined 26 cases of primary testis cancer using immunohistochemical staining and Western blot analysis.
Participant Demographics
Mean age at surgery was 36 years, with a range of 6 months to 87 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website